胶质瘤MR成像进展:神经外科医生需要了解的内容
本综述阐述高级MRI技术在高级别胶质瘤全程管理中的作用:诊断时PWI与DWI有助鉴别肿瘤与类似病变,术前fMRI与DTI支持安全切除规划,术后及随访中MRI用于评估残留、并发症并鉴别真性进展与假性进展或放射性坏死。
要点
- PWI与DWI可提高诊断特异性,避免对肿瘤类似病变的不必要手术。
- fMRI与DTI有助定位功能区皮层与白质束,支持手术轨迹规划与风险评估。
- 术后及随访MRI有助鉴别真性进展与假性进展或放射性坏死,指导治疗决策。
核心结论
- 高级MRI技术在高级别胶质瘤诊疗各阶段均可为临床决策提供信息支持。
研究设计与样本
- 本篇为综述,汇总高级MRI技术在高级别胶质瘤全程管理中的应用进展。
主要发现
- 灌注加权成像(PWI)与弥散加权成像(DWI)可提高诊断特异性,并可能避免不必要的手术干预。
- 功能MRI(fMRI)与弥散张量成像(DTI)可定位功能区皮层与白质束,支持更安全的切除。
- 磁共振波谱、酰胺质子转移成像与2HG定量等新兴技术有望描绘对比增强边缘以外的肿瘤浸润。
- 术后MRI用于评估残留肿瘤、检测手术并发症并指导放疗规划。
- 治疗监测中MRI有助区分真性进展与假性进展或放射性坏死,从而指导是否再次手术、调整系统治疗或纳入临床试验。
临床怎么用
- 初诊时联合PWI与DWI提高诊断特异性,减少对肿瘤类似病变的不必要手术。
- 术前用fMRI与DTI定位功能区与白质束,辅助轨迹规划与风险评估。
- 术后及随访用MRI评估残留、并发症并鉴别真性进展与假性进展或放射性坏死。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glial tumors and especially glioblastoma present a major challenge in neuro-oncology due to their infiltrative growth, resistance to therapy, and poor overall survival-despite aggressive treatments such as maximal safe resection and chemoradiotherapy. These tumors typically manifest through neurological symptoms such as seizures, headaches, and signs of increased intracranial pressure, prompting urgent neuroimaging. At initial diagnosis, MRI plays a central role in differentiating true neoplasms from tumor mimics, including inflammatory or infectious conditions. Advanced techniques such as perfusion-weighted imaging (PWI) and diffusion-weighted imaging (DWI) enhance diagnostic specificity and may prevent unnecessary surgical intervention. In the preoperative phase, MRI contributes to surgical planning through the use of functional MRI (fMRI) and diffusion tensor imaging (DTI), enabling localization of eloquent cortex and white matter tracts. These modalities support safer resections by informing trajectory planning and risk assessment. Emerging MR techniques, including magnetic resonance spectroscopy, amide proton transfer imaging, and 2HG quantification, offer further potential in delineating tumor infiltration beyond contrast-enhancing margins. Postoperatively, MRI is important for evaluating residual tumor, detecting surgical complications, and guiding radiotherapy planning. During treatment surveillance, MRI assists in distinguishing true progression from pseudoprogression or radiation necrosis, thereby guiding decisions on additional surgery, changes in systemic therapy, or inclusion into clinical trials. The continued evolution of MRI hardware, software, and image analysis-particularly with the integration of machine learning-will be critical for supporting precision neurosurgical oncology. This review highlights how advanced MRI techniques can inform clinical decision-making at each stage of care in patients with high-grade gliomas.
引用
- Falk Delgado A. Advances of MR imaging in glioma: what the neurosurgeon needs to know. Acta Neurochir (Wien). 2025. PMID: 40542873. doi:10.1007/s00701-025-06593-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。